IFRD2 inhibitors represent a class of chemical compounds that specifically interact with and inhibit the activity of the IFRD2 protein. IFRD2, short for Interferon-related developmental regulator 2, is a protein that belongs to the broader family of transcriptional regulators. These inhibitors function by interfering with the normal biochemical processes of IFRD2, altering its capacity to modulate gene expression. The inhibition mechanism typically involves binding directly to the IFRD2 protein or associated regulatory elements, thereby affecting the protein's ability to participate in cellular pathways. As a transcriptional regulator, IFRD2 plays a significant role in cell differentiation, development, and possibly cellular stress responses, and its inhibition can result in a downstream impact on multiple biological processes, including cell cycle regulation, gene expression, and cellular signaling cascades.
From a molecular perspective, IFRD2 inhibitors can vary widely in their structure, ranging from small organic molecules to more complex chemical entities designed to fit specific binding pockets on the protein. The design and development of such inhibitors often involve detailed structural analysis of IFRD2, such as crystallography or molecular modeling, to identify regions critical for its function. By targeting these regions, researchers aim to disrupt key protein-protein interactions or DNA binding events necessary for IFRD2's role in gene regulation. The inhibition of IFRD2 can be selective or broad, depending on the specificity of the inhibitor, and can have diverse effects on cellular function depending on the cell type and the pathway in which IFRD2 is involved.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Immunosuppressant, inhibits calcineurin, potentially affecting pathways involving IFRD2. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Calcineurin inhibitor, may indirectly influence IFRD2 through immunomodulatory pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, potentially affecting cell differentiation and immune response related to IFRD2. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid, may modulate immune response and inflammation, indirectly influencing IFRD2. | ||||||
Prednisone | 53-03-2 | sc-205816 sc-205816A sc-205816B | 1 g 5 g 25 g | $42.00 $136.00 $676.00 | 2 | |
Glucocorticoid, can modulate immune pathways potentially affecting IFRD2. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Inhibits dihydrofolate reductase, affecting immune cell proliferation, possibly influencing IFRD2. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Immunosuppressive, inhibits purine synthesis, potentially impacting IFRD2-related pathways. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $37.00 $109.00 | 1 | |
Inhibits inosine monophosphate dehydrogenase, affecting lymphocyte proliferation, potentially influencing IFRD2. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibit NF-κB pathway, potentially affecting processes related to IFRD2's function. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Anti-inflammatory, may indirectly influence IFRD2 through modulation of immune response. | ||||||